Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure-Reference-Cited by-同舟云学术

Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure

Published:2021-07 Issue:7 Volume:9 Page:497-505
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Fuery Michael A.,Chouairi Fouad,Januzzi James L.,Moe Gordon W.,Caraballo Cesar,McCullough Megan,Miller P. Elliott,Reinhardt Samuel W.,Clark Katherine,Oseran Andrew,Milner Aidan,Pacor Justin,Kahn Peter A.,Singh Avinainder,Ravindra Neal,Guha Avirup,Vadlamani Lina,Kulkarni Neeti S.,Fiuzat Mona,Felker G. Michael,O’Connor Christopher M.,Ahmad Tariq,Ezekowitz Justin,Desai Nihar R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

2. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial;Pfeffer;Circulation,2015

3. Effect of nesiritide in patients with acute decompensated heart failure;O’Connor;N Engl J Med,2011

4. Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States;Kaul;J Am Coll Cardiol HF,2013

5. Trends in readmissions and length of stay for patients hospitalized with heart failure in Canada and the United States;Samsky;JAMA Cardiol,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction;Circulation;2023-10-10

2. Defining pharmacist activities in ambulatory heart failure clinics: North American survey and modified Delphi study;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-07-13

3. Regional variations in heart failure: a global perspective;Heart;2023-06-23

4. Cost Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Compared with Mineralocorticoid Receptor Antagonists among Patients with Heart Failure and a Reduced Ejection Fraction;Cardiovascular Innovations and Applications;2023

5. Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: Scoping Review Protocol;2022-07-07